Events

Join experts from Dr. Vince Clinical Research, along with moderator Polly Dawkins of the Davis Phinney Foundation, for a practical discussion on designing and executing successful Parkinson’s disease clinical trials. The session will explore symptomatic and disease-modifying study designs, endpoint selection, emerging research trends and operational challenges. Attendees will gain real-world insights to help advance...

A practical framework for reducing variability, minimizing manual sampling, and improving run-to-run consistency with modern UF/DF control strategies. August 26, 2026 | 11:00 AM ET Ultrafiltration Diafiltration (UF/DF) is often treated as a straightforward concentration and buffer-exchange step, but teams know the reality looks different. Small differences in setup, endpoint definition, and in-process decision-making can...

Are you making the most of your time at CPHI Milan? Watch this free virtual event to evaluate CDMOs, CMOs, API suppliers, packaging providers, and other outsourcing partners before you arrive onsite. Gain early insight into supplier capabilities, compare potential partners, and build a focused meeting strategy that maximizes your time at CPHI Milan. Register...

In this practical session, Jake Walton, VP of Quality & Compliance at MasterControl, will share a candid look at how MasterControl approached AI the right way from the start—building human-in-the-loop architecture as a non-negotiable design principle, aligning every capability to 21 CFR Part 11, EU MDR, GDPR, HIPAA, and other applicable standards, and going all...

A contamination control strategy (CCS) is usually treated as a document with sixteen elements assembled, signed, and shelved. This webinar offers a new perspective of a CCS as a machine that is not so complex that it cannot be analyzed component by component.

Successfully scaling a purification process from development to GMP manufacturing requires maintaining process performance while minimizing variability. However, scale-up often introduces challenges that can impact productivity, recovery, and overall process efficiency. To mitigate risk, manufacturers frequently apply conservative safety factors during scale-up—resulting in lower resin utilization, increased buffer consumption, longer process times, and reduced overall...